TriRadial Blog

Steering The Ship

TriRadial Blog

Steering
The Ship

Recent Posts

How FDA’s publishing of Complete Response Letters impacts your clinical risk mitigation strategy

July 28, 2025
Under its new leadership, FDA has started publishing its Complete Response Letters (CRLs) for public consumption...

How to Navigate FDA’s New Priorities

July 11, 2025
Recently the United States Commissioner of Food and Drugs, Martin Makary, MD. MPH, and the Director of the Center for...

What does the move to QMSR and the implications of ICHE6(R3) mean for clinical stage biotechs?

June 25, 2025
In less than a year, two major updates to Quality regulations will go into effect in the European Union and United...

Are you maximizing the value of your asset for out-licensing?

June 4, 2025
It is increasingly common for biotech companies to develop products to the point of Proof of Concept or late Phase 2...
  • There are no suggestions because the search field is empty.